159 related articles for article (PubMed ID: 30454893)
21. Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy.
Xie K; Xu C; Zhang M; Wang M; Min L; Qian C; Wang Q; Ni Z; Mou S; Dai H; Pang H; Gu L
Cell Death Dis; 2019 Dec; 10(12):915. PubMed ID: 31801948
[TBL] [Abstract][Full Text] [Related]
22. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
24. Role of nephrin in podocyte injury induced by angiotension II.
Yu S
J Recept Signal Transduct Res; 2016; 36(1):1-5. PubMed ID: 25264225
[TBL] [Abstract][Full Text] [Related]
25. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
[TBL] [Abstract][Full Text] [Related]
26. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
[TBL] [Abstract][Full Text] [Related]
27. Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.
Verma R; Venkatareddy M; Kalinowski A; Patel SR; Salant DJ; Garg P
Mol Cell Biol; 2016 Feb; 36(4):596-614. PubMed ID: 26644409
[TBL] [Abstract][Full Text] [Related]
28. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
29. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
[TBL] [Abstract][Full Text] [Related]
30. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
31. mPGES-1-derived PGE2 contributes to adriamycin-induced podocyte injury.
Yu J; Gong W; Wu Y; Li S; Cui Y; Ma Y; Zhang Y; Yang G; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F492-8. PubMed ID: 26739892
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin 1 Deficiency Ameliorates the Development of Adriamycin-Induced Proteinuric Kidney Disease.
Maimaitiyiming H; Zhou Q; Wang S
PLoS One; 2016; 11(5):e0156144. PubMed ID: 27196103
[TBL] [Abstract][Full Text] [Related]
33. Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression.
Ito Y; Katayama K; Nishibori Y; Akimoto Y; Kudo A; Kurayama R; Hada I; Takahashi S; Kimura T; Fukutomi T; Katada T; Suehiro J; Beltcheva O; Tryggvason K; Yan K
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1184-F1199. PubMed ID: 28228401
[TBL] [Abstract][Full Text] [Related]
34. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
[TBL] [Abstract][Full Text] [Related]
35. IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.
Liu Y; Liang W; Yang Y; Pan Y; Yang Q; Chen X; Singhal PC; Ding G
Cell Signal; 2015 Apr; 27(4):867-77. PubMed ID: 25652011
[TBL] [Abstract][Full Text] [Related]
36. [Dexamethasone Blocks Adriamycin-induced Podocytes'Mobility via Impacting Nephrin Expression].
Qiu B; Gao X; Cui WJ; Lei XY; Niu CH; Liu HJ; Zhang M; Liu QJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):197-202. PubMed ID: 31106539
[TBL] [Abstract][Full Text] [Related]
37. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.
Angeletti A; Cantarelli C; Petrosyan A; Andrighetto S; Budge K; D'Agati VD; Hartzell S; Malvi D; Donadei C; Thurman JM; Galešić-Ljubanović D; He JC; Xiao W; Campbell KN; Wong J; Fischman C; Manrique J; Zaza G; Fiaccadori E; La Manna G; Fribourg M; Leventhal J; Da Sacco S; Perin L; Heeger PS; Cravedi P
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32717081
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of glomerular filtration barrier damage in adriamycin-induced nephropathic rats with bufalin: an antiproteinuric agent.
Zheng J; Gong J; Zhang A; Li S; Zeng Z; Han Y; Gan W
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):107-14. PubMed ID: 22207085
[TBL] [Abstract][Full Text] [Related]
40. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
